tbuckley/cabot-search huggingface dataset:
CAN WE PREDICT THE PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT USING DEEP LEARNING? AN EXPERIENCE FROM URBAN HEALTHCARE SYSTEM
Authors: Chayakrit Krittanawong, Hafeez Hassan, Faisal Inayat, Bing Yue, Scott Kaplin, Ameesh Isath, Joshua Hahn, Kevin Greason, Mahboob Alam, Steven Filby
Journal: Journal of the American College of Cardiology (2021)
In situ bone regeneration with sequential delivery of aptamer and BMP2 from an ECM-based scaffold fabricated by cryogenic free-form extrusion
Authors: Tingfang Sun, Chunqing Meng, Qiuyue Ding, Keda Yu, Xianglin Zhang, Wancheng Zhang, Wenqing Tian, Qi Zhang, Xiaodong Guo, Bin Wu, Zekang Xiong
Journal: Bioactive Materials (2021)

In situ tissue engineering is a powerful strategy for the treatment of bone defects. It could overcome the limitations of traditional bone tissue engineering, which typically involves extensive cell expansion steps, low cell survival rates upon transplantation, and a risk of immuno-rejection. Here, a porous scaffold polycaprolactone (PCL)/decellularized small intestine submucosa (SIS) was fabricated via cryogenic free-form extrusion, followed by surface modification with aptamer and PlGF-2123-144*-fused BMP2 (pBMP2). The two bioactive molecules were delivered sequentially. The aptamer Apt19s, which exhibited binding affinity to bone marrow-derived mesenchymal stem cells (BMSCs), was quickly released, facilitating the mobilization and recruitment of host BMSCs. BMP2 fused with a PlGF-2123-144 peptide, which showed “super-affinity” to the ECM matrix, was released in a slow and sustained manner, inducing BMSC osteogenic differentiation. In vitro results showed that the sequential release of PCL/SIS-pBMP2-Apt19s promoted cell migration, proliferation, alkaline phosphatase activity, and mRNA expression of osteogenesis-related genes. The in vivo results demonstrated that the sequential release system of PCL/SIS-pBMP2-Apt19s evidently increased bone formation in rat calvarial critical-sized defects compared to the sequential release system of PCL/SIS-BMP2-Apt19s. Thus, the novel delivery system shows potential as an ideal alternative for achieving cell-free scaffold-based bone regeneration in situ.
PROGNOSTIC VALUE OF RIGHT VENTRICULAR DYSSYNCHRONY MEASUREMENTS AND MYOCARDIAL STRAIN ANALYSIS USING CARDIAC MAGNETIC RESONANCE IMAGING IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Authors: Matthew Thomas, Menhel Kinno, Brett Curran, Mushabbar Syed, Mark Rabbat
Journal: Journal of the American College of Cardiology (2021)
Prognostic Value of Electrocardiographic QRS Diminution in Patients With COVID-19
Authors: Joshua Lampert, Michael Miller, Jonathan L. Halperin, Connor Oates, Gennaro Giustino, Jason Feinman, Marc A. Miller, Srinivas R. Dukkipati, Martin E. Goldman, Vivek Y. Reddy
Journal: Journal of the American College of Cardiology (2021)
The Role of Comprehensive Mutational Profiling in Predicting Patients Who May Benefit from Autologous Hematopoietic Cell Transplant for Acute Myeloid Leukemia
Authors: Gabriel N. Mannis, Nicole Therrien, Jessica Van Ziffle, Nicole Foley, Iwei Yeh, Shan Zhong, Jie He, Michelle Nahas, Charalambos Andreadis, Lloyd E. Damon, Rebecca L. Olin, Sonam Prakash, Tariq I Mughal, Aaron C. Logan, Thomas G. Martin
Journal: Blood (2017)
Risk evaluation of duodenoscope-associated infections in the Netherlands calls for a heightened awareness of device-related infections: a systematic review
Authors: Judith A. Kwakman, Nicole S. Erler, Margreet C. Vos, Marco J. Bruno
Journal: Endoscopy (2021)

Abstract Background The risk of exogenous infections from endoscopic procedures is often cited as almost negligible (1 infection in 1.8 million procedures); however, this risk is based on older literature and does not seem to match the number of infectious outbreaks due to contaminated duodenoscopes reported after endoscopic retrograde cholangiopancreatography (ERCP). Using Dutch data, we aimed to estimate the minimum risk of duodenoscope-associated infection (DAI) and colonization (DAC) in patients undergoing ERCP. Methods A systematic literature search identified all DAI outbreaks in the Netherlands reported between 2008 and 2019. Included cases were confirmed by molecular matching of patient and duodenoscope cultures. Risk ratios were calculated based on the total number of ERCPs performed during the study period. Results Three outbreaks were reported and published between 2008 and 2018, including 21 confirmed DAI cases and 52 confirmed DAC cases. The estimated number of ERCPs performed during the same period was 181 209–227 006. The calculated minimum estimated DAI risk was approximately 0.01 % and the minimum estimated DAC risk was 0.023 %–0.029 %. Conclusions The estimated risk of DAI in Dutch ERCP practice was at least 180 times higher than previously published risk estimates. The actual risk is likely to be (much) higher due to underreporting of infections caused by multidrug-resistant organisms and sensitive bacteria. Greater awareness by healthcare personnel involved in endoscopy and endoscope cleaning is required, as well as innovative technical solutions to contain and ultimately eliminate DAIs.
QAUST: Protein Function Prediction Using Structure Similarity, Protein Interaction, and Functional Motifs
Authors: Fatima Zohra Smaili, Shuye Tian, Ambrish Roy, Meshari Alazmi, Stefan T. Arold, Srayanta Mukherjee, P. Scott Hefty, Wei Chen, Xin Gao
Journal: Genomics Proteomics & Bioinformatics (2021)

The number of available protein sequences in public databases is increasing exponentially. However, a significant percentage of these sequences lack functional annotation, which is essential for the understanding of how biological systems operate. Here, we propose a novel method, Quantitative Annotation of Unknown STructure (QAUST), to infer protein functions, specifically Gene Ontology (GO) terms and Enzyme Commission (EC) numbers. QAUST uses three sources of information: structure information encoded by global and local structure similarity search, biological network information inferred by protein-protein interaction data, and sequence information extracted from functionally discriminative sequence motifs. These three pieces of information are combined by consensus averaging to make the final prediction. Our approach has been tested on 500 protein targets from the Critical Assessment of Functional Annotation (CAFA) benchmark set. The results show that our method provides accurate functional annotation and outperforms other prediction methods based on sequence similarity search or threading. We further demonstrate that a previously unknown function of human tripartite motif-containing 22 (TRIM22) protein predicted by QAUST can be experimentally validated.
Gender-Affirming Surgeries and Improved Psychosocial Health Outcomes
Authors: Andrew A. Marano, Matthew R. Louis, Devin Coon
Journal: JAMA Surgery (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
Abstract 15532: Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and a Worsening Heart Failure Event
Authors: Anthony P CARNICELLI, Robert M Clare, Paul Hofmann, Karen Chiswell, Adam D Devore, Sreekanth Vemulapalli, Michael Felker, Phil Sarocco, Robert J Mentz
Journal: Circulation (2020)

Background: Several recent heart failure trials enrolled patients with heart failure with reduced ejection fraction (HFrEF) who had a worsening heart failure (WHF) event. Aim: To describe the characteristics and outcomes of patients with HFrEF and a WHF event at a large tertiary medical center. Methods: We identified patients 18-85 years of age with chronic symptomatic HFrEF (EF ≤35% and ≥2 HF encounters in the prior 18 months) treated at Duke University between Jan 2009-Dec 2018 through the Duke Echo Lab Database. A WHF event was defined as either a hospitalization or ED visit for HF in the prior 12 mos. A set of exclusion criteria [e.g., renal dysfunction, left ventricular assist device (LVAD), heart transplant] were applied to patients with a WHF event to generate a patient cohort similar to those enrolled in contemporary HF trials. We did not restrict the cohort based on BP or BNP levels since these vary over time. Baseline characteristics and outcomes including death and hospitalization were assessed. Results: Of 4846 unique patients with HFrEF, 3668 (76%) had a WHF event in the year prior to index echo. Sequentially, patients with GFR &lt;20 mL/min/1.73 m 2 (n=458), LVAD (n=291), or heart transplant (n=95) were excluded; 2824/4846 (58%) remained in the WHF study population. HFrEF patients with WHF were typically men (68%) with median age of 65 years (IQR 54, 73) and low EF (EF &lt;25% in 57%). Coronary disease (71%), diabetes (44%), and elevated NT-proBNP (median 2405 pg/mL [698, 6841]) were common. Beta-blocker, ACEi/ARB, and MRA use were 88%, 79% and 44%, respectively. HFrEF patients with WHF had a high 30-day, 1-year, and 5-year cumulative incidence of all-cause mortality and HF hospitalization after index echo (FIGURE). Conclusions: In patients with chronic HFrEF at Duke University, 76% had a WHF event in the past year and 58% met several of the key eligibility criteria of contemporary HF trials. Patients with recent WHF had a high burden of comorbidities and very high event rates.
BLEEDING RISK IN ELDERLY PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
Authors: Rishi Chandiramani, Roxana Mehran, Robert Faillace, Davide Cao, Samantha Sartori, Johny Nicolas, Mauro Chiarito, Ridhima Goel, Anastasios Roumeliotis, Matteo Nardin, Giulio Stefanini, Prakash Krishnan, Nitin Barman, Joseph Sweeny, Usman Baber, George Dangas, Samin Sharma, Annapoorna Kini
Journal: Journal of the American College of Cardiology (2021)
The Habitat Filters of Microbiota-Nourishing Immunity
Authors: Brittany M. Miller, Andreas J. Bäumler
Journal: Annual Review of Immunology (2021)

An imbalance in the microbiota may contribute to many human illnesses, which has prompted efforts to rebalance it by targeting the microbes themselves. However, by supplying the habitat, the host wields a prominent influence over microbial growth at body surfaces, raising the possibility that rebalancing the microbiota by targeting our immune system would be a viable alternative. Host control mechanisms that sculpt the microbial habitat form a functional unit with the microbiota, termed microbiota-nourishing immunity, that confers colonization resistance against pathogens. The host components of microbiota-nourishing immunity can be viewed as habitat filters that select for microbial traits licensing growth and survival in host habitat patches. Here we review current knowledge of how host-derived habitat filters shape the size, species composition, and spatial heterogeneity of the microbiota and discuss whether these host control mechanisms could be harnessed for developing approaches to rebalance microbial communities during dysbiosis.
Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients
Authors: Fabio Guolo, Paola Minetto, Marino Clavio, Nicoletta Colombo, Annalisa Kunkl, Enrico Carminati, Carmen Di Grazia, Anna Maria Raiola, Filippo Ballerini, Maurizio Miglino, Emanuele Angelucci, Roberto M Lemoli, Marco Gobbi
Journal: Blood (2017)
CHRONIC TREATMENT WITH A MAVACAMTEN-LIKE MYOSIN-MODULATOR (MYK-581) DECREASES LEFT-VENTRICULAR FIBROSIS AND GLUCOSE UPTAKE WHILE BLUNTING MORTALITY IN A MINI-PIG MODEL OF INHERITED HYPERTROPHIC CARDIOMYOPATHY
Authors: David Ryba, Trisha Smit, Frank Rohret, Julie Grinde, Vidya Sridhar, Carlos L. del Rio
Journal: Journal of the American College of Cardiology (2021)
RETROSPECTIVE OBSERVATION STUDY TO COMPARE THE EFFICACY AND SAFETY BETWEEN TWO ULTRATHIN DRUG-ELUTING STENTS - GENOSS DES VS. ORSIRO
Authors: Young Jin Youn, Se-Eun Kim, Dong-Hyuk Cho, Jun-Won Lee, Young Jun Park, Jung-Woo Son, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon
Journal: Journal of the American College of Cardiology (2021)
Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
Authors: Monde Muyoyeta, Andrew D. Kerkhoff, Lophina Chilukutu, Emmanuel Moreau, Samuel G. Schumacher, Morten Ruhwald
Journal: European Respiratory Journal (2021)

A novel, rapid, point-of-care urine-based lipoarabinomannan assay (Fujifilm SILVAMP TB LAM ("FujiLAM")) has previously demonstrated substantially higher sensitivity for tuberculosis (TB) compared with the commercially available Determine TB LAM assay using biobanked specimens. However, FujiLAM has not been prospectively evaluated using fresh urine specimens. Therefore, we determined the diagnostic accuracy of FujiLAM among HIV-positive and HIV-negative outpatients with presumptive TB in Zambia.Adult (≥18 years old) presumptive TB patients presenting to two outpatient public health facilities in Lusaka were included. All patients submitted sputa samples for smear microscopy, Xpert MTB/RIF and mycobacterial culture, and urine samples for the FujiLAM assay. Microbiologically confirmed TB was defined by the detection of Mycobacterium tuberculosis in sputum using culture; this served as the reference standard to assess the diagnostic accuracy of FujiLAM.151 adults with paired sputum microbiological tests and urine FujiLAM results were included; 45% were HIV-positive. Overall, 34 out of 151 (23%) patients had culture-confirmed pulmonary TB. The overall sensitivity and specificity of FujiLAM was 77% (95% CI 59-89%) and 92% (95% CI 86-96%), respectively. FujiLAM's sensitivity among HIV-positive patients was 75% (95% CI 43-95%) compared with 75% (95% CI 51-91%) among HIV-negative patients. The sensitivity of FujiLAM in patients with smear-positive, confirmed pulmonary TB was 87% (95% CI 60-98%) compared with 68% (95% CI 43-87%) among patients with smear-negative, confirmed pulmonary TB.FujiLAM demonstrated high sensitivity for the detection of TB among both HIV-positive and HIV-negative adults, and also demonstrated good specificity despite the lack of systematic extrapulmonary sampling to inform a comprehensive microbiological reference standard.
ATHEROSCLEROTIC CORONARY DISEASE IN A YOUNG ADULT WITH ALCA: THE ROLE OF MULTIMODALITY EVALUATION IN A RARE ASSOCIATION
Authors: Eunwoo Park, Payush Chatta, Anas Alani, Dennis Grewal, Anees Razzouk, David Rabkin, Purvi Parwani, Ahmed Kheiwa
Journal: Journal of the American College of Cardiology (2021)
PREDICTIVE PERFORMANCE OF A POLYGENIC RISK SCORE FOR INCIDENT ISCHEMIC STROKE IN A HEALTHY OLDER POPULATION
Authors: Johannes Neumann, Moeen Riaz, Andrew Bakshi, Galina Polekhina, Le Thao, Mark Nelson, Robyn Woods, Gad Abraham, Michael Inouye, Christopher Reid, Andrew Tonkin, Jeff Williamson, Geoffrey Donnan, Amy Brodtmann, Geoffrey Cloud, John McNeil, Paul Lacaze
Journal: Journal of the American College of Cardiology (2021)
The Effect of Rivaroxaban Exposure and Clinical Risk Factors on Efficacy and Safety Outcomes in Patients with Nonvalvular Atrial Fibrillation
Authors: Xiaoyu Yan, Gary Peters, Amarnath Sharma, Partha Nandy, Christopher Nessel, Dirk Garmann, Stefan Willmann, Anne Hermanowski-Vosatka, Alexander Solms, Scott D. Berkowitz, Theodore E Spiro, Keith A A Fox, Jeffrey I Weitz, Stephan Schmidt, Jonathan P Piccini, Manesh Patel, Richard C Becker, Liping Zhang
Journal: Blood (2017)
POSTADMISSION STATIN USE IS ASSOCIATED WITH REDUCED 1-YEAR MORTALITY IN INFECTIVE ENDOCARDITIS: A TERRITORY WIDE STUDY
Authors: Si Yeung Yu, Qing Wen Ren, Hang Long Li, Mei Zhen Wu, Pui Fai Wong, Kai Hang Yiu
Journal: Journal of the American College of Cardiology (2021)
DEEP PHENOTYPING BY UNSUPERVISED MACHINE LEARNING OF PARTICIPANTS IN THE BARI 2D TRIAL
Authors: Gauri Dandi, Nuha Gani, Zyannah Mallick, Ian Atkinson, Kabir Al-Tariq, Victoria Xin, Areeb Gani, Scout Hayashi, Natalie Lewis, Nayab Mahmood, Khizar Qureshi, Avantika Banerjee, Amit Dey, Anwar Husain, Yves Rosenberg, Ahmed Hasan
Journal: Journal of the American College of Cardiology (2021)
Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
Authors: David Montani, Laurent Savale, Antoine Beurnier, Romain Colle, Nicolas Noël, Tài Pham, Xavier Monnet, Marc Humbert
Journal: European Respiratory Journal (2021)

<b>The importance of the COVID-19 pandemic requires us to break down the walls between medical specialties to optimise the management of patients with post-acute COVID-19 syndrome</b>https://bit.ly/3gzqEik
Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation
Authors: Jiao-Hui Wu, Lisheng Zhang, Igor Nepliouev, Leigh Brian, Taiqin Huang, Kamie P Snow, Brandon M Schickling, Elizabeth R Hauser, Francis J Miller, Neil J Freedman, Jonathan A Stiber
Journal: Cardiovascular Research (2021)

Abstract Aims The F-actin-binding protein Drebrin inhibits smooth muscle cell (SMC) migration, proliferation, and pro-inflammatory signalling. Therefore, we tested the hypothesis that Drebrin constrains atherosclerosis. Methods and results SM22-Cre+/Dbnflox/flox/Ldlr−/− (SMC-Dbn−/−/Ldlr−/−) and control mice (SM22-Cre+/Ldlr−/−, Dbnflox/flox/Ldlr−/−, and Ldlr−/−) were fed a western diet for 14–20 weeks. Brachiocephalic arteries of SMC-Dbn −/−/Ldlr−/− mice exhibited 1.5- or 1.8-fold greater cross-sectional lesion area than control mice at 14 or 20 weeks, respectively. Aortic atherosclerotic lesion surface area was 1.2-fold greater in SMC-Dbn−/−/Ldlr−/− mice. SMC-Dbn−/−/Ldlr−/− lesions comprised necrotic cores that were two-fold greater in size than those of control mice. Consistent with their bigger necrotic core size, lesions in SMC-Dbn−/− arteries also showed more transdifferentiation of SMCs to macrophage-like cells: 1.5- to 2.5-fold greater, assessed with BODIPY or with CD68, respectively. In vitro data were concordant: Dbn−/− SMCs had 1.7-fold higher levels of KLF4 and transdifferentiated to macrophage-like cells more readily than Dbnflox/flox SMCs upon cholesterol loading, as evidenced by greater up-regulation of CD68 and galectin-3. Adenovirally mediated Drebrin rescue produced equivalent levels of macrophage-like transdifferentiation in Dbn−/− and Dbnflox/flox SMCs. During early atherogenesis, SMC-Dbn−/−/Ldlr−/− aortas demonstrated 1.6-fold higher levels of reactive oxygen species than control mouse aortas. The 1.8-fold higher levels of Nox1 in Dbn−/− SMCs were reduced to WT levels with KLF4 silencing. Inhibition of Nox1 chemically or with siRNA produced equivalent levels of macrophage-like transdifferentiation in Dbn−/− and Dbnflox/flox SMCs. Conclusion We conclude that SMC Drebrin limits atherosclerosis by constraining SMC Nox1 activity and SMC transdifferentiation to macrophage-like cells.
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial
Authors: Michiel S. van der Heijden, Yohann Loriot, Ignacio Durán, Alain Ravaud, Margitta Retz, Nicholas J. Vogelzang, Betty Nelson, Jingjing Wang, Xiaodong Shen, Thomas Powles
Journal: European Urology (2021)
Does PROVE-IT Really Prove Anything of Value?
Authors: Yuri W. Novitsky, Omar M. Ghanem, Bruce Ramshaw
Journal: JAMA Surgery (2021)

To the Editor It is with interest that we read the study by Petro et al.1 While we commend the authors for tackling timely clinical questions, we have significant concerns about PROVE-IT methodology and resultant overstated conclusions.
Publisher Correction: Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group
Authors: Olivia Boyer, Franz Schaefer, Dieter Haffner, Detlef Bockenhauer, Tuula Hölttä, Sandra Bérody, Hazel Webb, Marie Heselden, Beata S. Lipska-Ziętkiewicz, Fatih Ozaltin, Elena Levtchenko, Marina Vivarelli
Journal: Nature Reviews Nephrology (2021)
Effect of Adjuvant Metronomic Capecitabine on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer—Reply
Authors: Xi-Wen Bi, Xin Hua, Zhong-Yu Yuan
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types
Authors: Jared J. Gartner, Maria R. Parkhurst, Alena Gros, Eric Tran, Mohammad S. Jafferji, Amy Copeland, Ken-Ichi Hanada, Nikolaos Zacharakis, Almin Lalani, Sri Krishna, Abraham Sachs, Todd D. Prickett, Yong F. Li, Maria Florentin, Scott Kivitz, Samuel C. Chatmon, Steven A. Rosenberg, Paul F. Robbins
Journal: Nature Cancer (2021)